Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.95
+0.18 (2.69%)
Mar 31, 2025, 3:39 PM EDT - Market open

Company Description

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.

The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services.

It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products.

The company also offers the supply of phytochemical reference standards and other research and development services.

In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name.

The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States.

The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025.

Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Niagen Bioscience, Inc.
Niagen Bioscience logo
Country United States
Founded 1999
Industry Biotechnology
Sector Healthcare
Employees 104
CEO Robert Fried

Contact Details

Address:
10900 Wilshire Blvd, Suite 600
Los Angeles, California 90024
United States
Phone 310 388 6706
Website niagenbioscience.com

Stock Details

Ticker Symbol NAGE
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001386570
CUSIP Number 171077407
ISIN Number US1710774076

Key Executives

Name Position
Robert N. Fried Chief Executive Officer and Director
Frank Louis Jaksch Jr. Co-Founder and Chairman
Ozan Pamir C.F.A. Chief Financial Officer and Principal Accounting Officer
Dr. Andrew Shao Ph.D. Senior Vice President of Global Regulatory and Scientific Affairs
Carlos Lopez Senior Vice President and General Counsel
Michiko Kelley Chief Marketing Officer
Chu Yan Managing Director of Asia Pacific
Kendall Knysch Head of Media Relations and Partnerships
James Lee Controller